
|Articles|December 19, 2005
Methotrexate lot recalled
Advertisement
Bedford Laboratories has recalled one lot of preservative-free Methotrexate for Injection because the active ingredient was contaminated with low levels of the preservative ethylene glycol. The affected lot is #859142, with a September 2007 expiry. Health professionals should not distribute the 1-gm vials (NDC 55390-143-01) and should contact Bedford Labs for return instructions. The complete FDA MedWatch safety summary is at
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
2
Zepbound Lowers Health Care Costs in Older Adults With Obesity
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Measles Resurgence Exposes US Vaccine Policy Risks, Experts Warn
5






































